Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07002866 · ClinicalTrials.gov registry record · NA

Suubi4PrEP: Improving PrEP Access and Adherence Among Adolescent Girls and Young Women in Uganda

A NA study of HIV Prevention, sponsored by Washington University School of Medicine.

Recruiting
Registry status
NA
Development phase
600
Enrollment target
2
Study locations

NCT07002866 is a NA study of HIV Prevention that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 600 participants, above the 363-participant average among 32 other HIV Prevention trials with a reported enrollment target (65% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07002866, a NA study of HIV Prevention, is actively recruiting participants, sponsored by Washington University School of Medicine.

RECRUITING
Registry status
NA
Development phase
600 participants
Enrollment target
2
Study locations

Study Summary

The study will employ a multilevel combination intervention focused on PrEP initiation and adherence among adolescent girls and young women (AGYW) (aged 15-24) living in HIV hotpots in Uganda. Specifically, the study will combine: 1) HIV risk reduction (HIVRR) that incorporates sessions on PrEP, 2) Peer Supporters (PS) with lived experiences taking PrEP to facilitate linkage to and continued care, share strategies to address misconceptions, manage disclosure and stigma, and model positive lifestyles while engaging in care services, and 3) an economic empowerment (EE) component that includes a matched savings account and financial literacy targeting poverty and financial barriers associated with PrEP access. Working within 30 health care systems, we will randomly assign 600 AGYW (at the community level) to one of three study arms (n=200 AGYW, n=10 sites per arm): 1) HIVRR only, 2) HIVRR+ PS, or 3) HIVRR + PS + EE. The interventions will be implemented for 20 months, and data collected at baseline, 12, 24, 36 months.

Conditions Studied

Interventions

  • BEHAVIORAL HIV Risk Reduction (HIVRR)
  • BEHAVIORAL PrEP Peer Supporters (PS)
  • BEHAVIORAL Matched Savings Accounts + Financial Literacy (FL)

Study Locations (2)

Missouri

  • Washington University in St. Louis - St Louis

Other

  • International Center for Child Health and Development (ICHAD) - Masaka

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2025-10-20
Est. Completion 2029-12-31
Phase NA

What the Registry Record Tells You About NCT07002866

The ClinicalTrials.gov registry entry for NCT07002866 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 363-participant average among 32 other HIV Prevention trials with a reported enrollment target (65% higher). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Prevention appearing as the primary indexed condition, and to 3 interventions - of which HIV Risk Reduction (HIVRR) is the first listed.

NCT07002866 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Missouri, Other.

Frequently Asked Questions

What is clinical trial NCT07002866 about?

NCT07002866 is a clinical study titled "Suubi4PrEP: Improving PrEP Access and Adherence Among Adolescent Girls and Young Women in Uganda". The study will employ a multilevel combination intervention focused on PrEP initiation and adherence among adolescent girls and young women (AGYW) (aged 15-24) living in HIV hotpots in Uganda. Specifically, the study will combine: 1) HIV risk reduction (HIVRR) that incorporates sessions on PrEP, 2) ...

What is the current status of trial NCT07002866?

This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2025-10-20. Estimated completion is 2029-12-31.

What conditions does trial NCT07002866 study?

This clinical trial studies the following conditions: HIV Prevention.

What interventions are being tested in trial NCT07002866?

The interventions under investigation include: HIV Risk Reduction (HIVRR) (BEHAVIORAL), PrEP Peer Supporters (PS) (BEHAVIORAL), Matched Savings Accounts + Financial Literacy (FL) (BEHAVIORAL).

Who is sponsoring clinical trial NCT07002866?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07002866 being conducted?

This trial has 2 study locations across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Prevention

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.